Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-Siglec-2/CD22 Antibody-PerCP (1M79)
🥰Excellent
Catalog No. TMAY-02165C
Anti-Siglec-2/CD22 Antibody-PerCP (1M79) is a PerCP-conjugated Mouse antibody targeting Siglec-2/CD22. Anti-Siglec-2/CD22 Antibody-PerCP (1M79) can be used in FCM.
Anti-Siglec-2/CD22 Antibody-PerCP (1M79)
Anti-Siglec-2/CD22 Antibody-PerCP (1M79)
🥰Excellent
Catalog No. TMAY-02165C
Anti-Siglec-2/CD22 Antibody-PerCP (1M79) is a PerCP-conjugated Mouse antibody targeting Siglec-2/CD22. Anti-Siglec-2/CD22 Antibody-PerCP (1M79) can be used in FCM.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-Siglec-2/CD22 Antibody-PerCP (1M79) is a PerCP-conjugated Mouse antibody targeting Siglec-2/CD22. Anti-Siglec-2/CD22 Antibody-PerCP (1M79) can be used in FCM. |
| Ig Type | Monoclonal Mouse IgG1 |
| Clone | 1M79 |
| Reactivity | Human |
| Verified Activity | Flow cytometric analysis of Human CD22 expression on human whole blood lymphocytes. Cells were stained with PerCP-conjugated anti-Human CD22 and APC-conjugated anti-Human CD19. The dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD22/Siglec-2 (rh CD22/Siglec-2; TMPY-02034; P20273-1; Met1-Arg687) and conjugated with PerCP under optimum conditions, the unreacted PerCP was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.09% sodium azide |
| Research Background | CD22 is a member of the immunoglobulin superfamily, SIGLEC family of lectins. It is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. CD22 serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. In addition to its potential role as a mediator of intercellular interactions, signal transduction through CD22 can activate B cells and modulate antigen receptor signaling in vitro. The phenotype of CD22-deficient mice suggests that CD22 is primarily involved in the generation of mature B cells within the bone marrow, blood, and marginal zones of lymphoid tissues. CD22 recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and inhibits B-cell receptor (BCR)-induced Ca2+ signaling on normal B cells. CD22 interacts specifically with ligands carrying alpha2-6-linked sialic acids. As an inhibitory coreceptor of the B-cell receptor (BCR), CD22 plays a critical role in establishing signalling thresholds for B-cell activation. Like other coreceptors, the ability of CD22 to modulate B-cell signalling is critically dependent upon its proximity to the BCR, and this in turn is governed by the binding of its extracellular domain to alpha2,6-linked sialic acid ligands. However, genetic studies in mice reveal that some CD22 functions are regulated by ligand binding, whereas other functions are ligand-independent and may only require expression of an intact CD22 cytoplasmic domain at the B-cell surface. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity, while CD22 inhibits CD19 phosphorylation via SHP-1.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Conjucates | PerCP |
| Others Formats | Unconjugated/FITC/PE |
| Antibody Types Available | 4 |
| Immunogen | Recombinant Human CD22/Siglec-2 Protein (TMPY-02034) |
| Antigen Species | Human |
| Biology Area | Cancer Drug Targets, ITIM/ITAM Immunoreceptors and Related Molecules |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-Siglec-2/CD22 Antibody-PerCP (1M79) | purchase Anti-Siglec-2/CD22 Antibody-PerCP (1M79) | Anti-Siglec-2/CD22 Antibody-PerCP (1M79) cost | order Anti-Siglec-2/CD22 Antibody-PerCP (1M79)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.